CN102342903B - 一种护肤组合物及其在预防和延缓皮肤衰老的用途与方法 - Google Patents
一种护肤组合物及其在预防和延缓皮肤衰老的用途与方法 Download PDFInfo
- Publication number
- CN102342903B CN102342903B CN 201110315909 CN201110315909A CN102342903B CN 102342903 B CN102342903 B CN 102342903B CN 201110315909 CN201110315909 CN 201110315909 CN 201110315909 A CN201110315909 A CN 201110315909A CN 102342903 B CN102342903 B CN 102342903B
- Authority
- CN
- China
- Prior art keywords
- skin
- resveratrol
- aging
- tea polyphenols
- care compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 230000009759 skin aging Effects 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 12
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 46
- 229940016667 resveratrol Drugs 0.000 claims abstract description 46
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 45
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 44
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 39
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 39
- 241001122767 Theaceae Species 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 235000002378 plant sterols Nutrition 0.000 claims description 23
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 21
- 229960002591 hydroxyproline Drugs 0.000 claims description 21
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 21
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 14
- 230000002265 prevention Effects 0.000 claims description 10
- 230000001815 facial effect Effects 0.000 claims description 8
- 239000008294 cold cream Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 230000032683 aging Effects 0.000 abstract description 14
- 230000003712 anti-aging effect Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 4
- 230000036285 pathological change Effects 0.000 abstract description 2
- 231100000915 pathological change Toxicity 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 32
- 238000003756 stirring Methods 0.000 description 28
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- 235000019437 butane-1,3-diol Nutrition 0.000 description 16
- 150000003254 radicals Chemical class 0.000 description 16
- 230000002421 anti-septic effect Effects 0.000 description 15
- 230000001804 emulsifying effect Effects 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 13
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 13
- 229940075529 glyceryl stearate Drugs 0.000 description 12
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 12
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 description 11
- 229940058015 1,3-butylene glycol Drugs 0.000 description 10
- 229940081733 cetearyl alcohol Drugs 0.000 description 10
- 229940008099 dimethicone Drugs 0.000 description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 10
- 239000002480 mineral oil Substances 0.000 description 10
- 235000010446 mineral oil Nutrition 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 10
- 239000012467 final product Substances 0.000 description 8
- 210000001061 forehead Anatomy 0.000 description 8
- 206010040954 Skin wrinkling Diseases 0.000 description 7
- 238000007599 discharging Methods 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000035618 desquamation Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 230000003005 anti-senility effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- TUUXBSASAQJECY-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 TUUXBSASAQJECY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- -1 flavanol compound Chemical class 0.000 description 2
- 235000011987 flavanols Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- PSFDQSOCUJVVGF-UHFFFAOYSA-N harman Chemical compound C12=CC=CC=C2NC2=C1C=CN=C2C PSFDQSOCUJVVGF-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FGMPLJWBKKVCDB-BYPYZUCNSA-N (2s)-1-hydroxypyrrolidine-2-carboxylic acid Chemical compound ON1CCC[C@H]1C(O)=O FGMPLJWBKKVCDB-BYPYZUCNSA-N 0.000 description 1
- KYBXNPIASYUWLN-WUCPZUCCSA-N (2s)-5-hydroxypyrrolidine-2-carboxylic acid Chemical compound OC1CC[C@@H](C(O)=O)N1 KYBXNPIASYUWLN-WUCPZUCCSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000003211 Corylus maxima Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000218665 Gnetaceae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108091093078 Pyrimidine dimer Proteins 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Chemical class 0.000 description 1
- 239000004410 anthocyanin Chemical class 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002648 azanetriyl group Chemical group *N(*)* 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012459 muffins Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013635 pyrimidine dimer Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 201000003385 seborrheic keratosis Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
成分 | wt% |
白藜芦醇 | 1.0 |
茶多酚 | 1.0 |
植物甾醇 | 10.0 |
羟脯氨酸 | 8.0 |
甘油硬脂酸酯柠檬酸酯 | 4.0 |
甘油硬脂酸酯 | 2.0 |
鲸蜡硬脂醇 | 2.0 |
矿物油 | 25.0 |
辛酸/癸酸甘油三酯 | 10.0 |
1,3-丁二醇 | 7.0 |
卡波U21 | 0.45 |
三乙醇胺 | 适量调pH值5.5-7.0 |
防腐剂、香精 | 适量 |
纯化水 | 至100 |
成分 | wt% |
白藜芦醇 | 2.0 |
茶多酚 | 40.0 |
1,3-丁二醇 | 30.0 |
防腐剂、水溶性香精 | 适量 |
纯化水 | 至100 |
成分 | wt% |
白藜芦醇 | 12.0 |
茶多酚 | 0.6 |
乙醇 | 至100 |
氮酮 | 2.0 |
香精 | 适量 |
成分 | wt% |
白藜芦醇 | 0.05 |
茶多酚 | 0.05 |
植物甾醇 | 0.15 |
羟脯氨酸 | 0.3 |
甘油硬脂酸酯柠檬酸酯 | 1.0 |
甘油硬脂酸酯 | 0.5 |
辛酸/癸酸甘油三酯 | 4.0 |
二甲基硅油 | 0.5 |
1,3-丁二醇 | 10.0 |
透明质酸钠 | 0.02 |
卡波U21 | 0.5 |
三乙醇胺 | 适量调pH值5.5-7.0 |
防腐剂、香精 | 适量 |
纯化水 | 至100 |
成分 | wt% |
白藜芦醇 | 0.2 |
茶多酚 | 0.01 |
植物甾醇 | 0.05 |
羟脯氨酸 | 0.1 |
甘油硬脂酸酯柠檬酸酯 | 2.0 |
甘油硬脂酸酯 | 1.0 |
鲸蜡硬脂醇 | 1.0 |
矿物油 | 4.0 |
辛酸/癸酸甘油三酯 | 6.0 |
二甲基硅油 | 1.0 |
1,3-丁二醇 | 20.0 |
卡波U21 | 0.4 |
三乙醇胺 | 适量调pH值5.5-7.0 |
防腐剂、香精 | 适量 |
纯化水 | 至100 |
成分 | wt% |
白藜芦醇 | 0.25 |
茶多酚 | 1.0 |
植物甾醇 | 0.25 |
羟脯氨酸 | 10.0 |
甘油硬脂酸酯柠檬酸酯 | 4.0 |
甘油硬脂酸酯 | 2.0 |
鲸蜡硬脂醇 | 2.0 |
矿物油 | 15.0 |
辛酸/癸酸甘油三酯 | 8.0 |
二甲基硅油 | 2.0 |
1,3-丁二醇 | 15.0 |
卡波U21 | 0.4 |
三乙醇胺 | 适量调pH值5.5-7.0 |
防腐剂、香精 | 适量 |
纯化水 | 至100 |
成分 | wt% |
白藜芦醇 | 0.17 |
茶多酚 | 0.27 |
植物甾醇 | 0.05 |
羟脯氨酸 | 1.67 |
甘油硬脂酸酯柠檬酸酯 | 2.0 |
甘油硬脂酸酯 | 1.0 |
鲸蜡硬脂醇 | 1.0 |
矿物油 | 5.0 |
辛酸/癸酸甘油三酯 | 10.0 |
二甲基硅油 | 1.0 |
1,3-丁二醇 | 10.0 |
卡波U21 | 0.4 |
三乙醇胺 | 适量调pH值5.5-7.0 |
防腐剂、香精 | 适量 |
纯化水 | 至100 |
成分 | wt% |
白藜芦醇 | 0.2 |
茶多酚 | 1.6 |
植物甾醇 | 0.1 |
羟脯氨酸 | 3.0 |
滑石粉 | 30.0 |
云母 | 49.0 |
甲基丙烯酸甲酯 | 2.0 |
霍霍巴油 | 9.0 |
1,3-丁二醇 | 5.1 |
成分 | wt% |
白藜芦醇 | 0.25 |
茶多酚 | 0.25 |
植物甾醇 | 2.5 |
羟脯氨酸 | 5.0 |
甘油硬脂酸酯柠檬酸酯 | 3.0 |
甘油硬脂酸酯 | 1.5 |
鲸蜡硬脂醇 | 2.0 |
矿物油 | 14.0 |
辛酸/癸酸甘油三酯 | 10.0 |
二甲基硅油 | 2.0 |
1,3-丁二醇 | 10.0 |
卡波U21 | 0.35 |
三乙醇胺 | 适量调pH值5.5-7.0 |
防腐剂、香精 | 适量 |
纯化水 | 至100 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110315909 CN102342903B (zh) | 2011-10-18 | 2011-10-18 | 一种护肤组合物及其在预防和延缓皮肤衰老的用途与方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110315909 CN102342903B (zh) | 2011-10-18 | 2011-10-18 | 一种护肤组合物及其在预防和延缓皮肤衰老的用途与方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102342903A CN102342903A (zh) | 2012-02-08 |
CN102342903B true CN102342903B (zh) | 2013-02-27 |
Family
ID=45542234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110315909 Active CN102342903B (zh) | 2011-10-18 | 2011-10-18 | 一种护肤组合物及其在预防和延缓皮肤衰老的用途与方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102342903B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103622875B (zh) * | 2013-12-04 | 2015-09-23 | 中国计量学院 | 儿茶素水凝胶护肤品的制备方法 |
CN103767884B (zh) * | 2014-01-02 | 2016-08-17 | 北京桑普生物化学技术有限公司 | 一种天然植物防腐剂组合物 |
CN104622758A (zh) * | 2015-02-11 | 2015-05-20 | 广州赛莱拉干细胞科技股份有限公司 | 一种茉莉花植物叶细胞提取物的制备方法及应用 |
CN104997693A (zh) * | 2015-07-31 | 2015-10-28 | 魏善众 | 植物甾醇酯化妆品 |
CN107582471A (zh) * | 2017-10-27 | 2018-01-16 | 丘少荣 | 一种皮肤抗衰老组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1313427A2 (en) * | 2000-07-10 | 2003-05-28 | The Procter & Gamble Company | Methods of enhancing delivery of oil-soluble skin care actives |
KR100521768B1 (ko) * | 2003-05-26 | 2005-10-17 | 엔프라니 주식회사 | 피부미백용 화장료 조성물 |
CN101621987B (zh) * | 2007-02-28 | 2013-08-21 | 宝洁公司 | 包含孟加拉榕树植物提取物的个人护理组合物 |
-
2011
- 2011-10-18 CN CN 201110315909 patent/CN102342903B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102342903A (zh) | 2012-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106580797B (zh) | 一种美白祛斑霜及其制备方法 | |
KR101769416B1 (ko) | 주름·미백 기능을 포함한 다중기능성 마스크용 화장품의 혼합 조성물 및 제조방법 | |
KR101059471B1 (ko) | 피부 노화 방지용 화장료 조성물 | |
CN103340817B (zh) | 一种葛根美白面膜 | |
KR101769422B1 (ko) | 다중기능성 세럼형 화장품의 혼합 조성물 및 제조방법 | |
KR101810231B1 (ko) | 프로폴리스 미세침 분말을 함유하는 화장료 조성물 | |
KR101769419B1 (ko) | 다중기능성 영양크림의 혼합 조성물 및 제조방법 | |
KR101809266B1 (ko) | 프로폴리스 복합 추출물을 함유하는 화장료 조성물 | |
WO2021104276A1 (zh) | 一种茯茶提取物在制备皮肤调节产品中的用途 | |
CN110302135A (zh) | 一种温和祛痘霜 | |
CN102342903B (zh) | 一种护肤组合物及其在预防和延缓皮肤衰老的用途与方法 | |
WO2019066121A1 (ko) | 식물 유래 세포 외 소포체를 포함하는 조성물 | |
CN103405380A (zh) | 一种银耳护肤组合物及其应用 | |
CN108078834A (zh) | 一种具有抑制黑色素和舒缓皮肤功效的组合物及其在化妆品中的应用 | |
KR20170137552A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
KR20170137544A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
CN111053731A (zh) | 一种保湿爽肤水 | |
CN111184824A (zh) | 一种祛斑中药液及其制备方法 | |
CN115778886A (zh) | 一种光甘草定植物源微囊包裹体及其制备方法与应用 | |
CN109481323A (zh) | 一种芦荟原汁保湿油及其制备方法 | |
EP3434256A1 (en) | Topical herbal compositions | |
JP3987733B2 (ja) | 線維芽細胞賦活剤及びこれを含む皮膚外用剤 | |
CN103860436A (zh) | 含有五味子提取物的化妆品组合物及美白滋养霜 | |
CN112957304A (zh) | 一种用于化妆品的植物组合物、混合提取液及制备方法 | |
KR20170136919A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ZHEJIANG KANGNUOBANG HEALTH PRODUCTS CO., LTD. Free format text: FORMER NAME: ZHEJIANG CONBA HEALTH PRODUCTS CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 310052 Binjiang District, Zhejiang Province, Hangzhou Road, No. 568 Patentee after: Zhejiang Kangnuobang Health Products Co., Ltd. Address before: 310052 Binjiang District, Zhejiang Province, Hangzhou Road, No. 568 Patentee before: Zhejiang Conba Health Products Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Skincare composition as well as use and method of same for preventing and delaying skin aging Effective date of registration: 20171220 Granted publication date: 20130227 Pledgee: China Everbright Bank Limited by Share Ltd Hangzhou branch Pledgor: Zhejiang Kangnuobang Health Products Co., Ltd. Registration number: 2017330000324 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181203 Granted publication date: 20130227 Pledgee: China Everbright Bank Limited by Share Ltd Hangzhou branch Pledgor: Zhejiang Kangnuobang Health Products Co., Ltd. Registration number: 2017330000324 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Skincare composition as well as use and method of same for preventing and delaying skin aging Effective date of registration: 20181205 Granted publication date: 20130227 Pledgee: China Everbright Bank Limited by Share Ltd Hangzhou branch Pledgor: Zhejiang Kangnuobang Health Products Co., Ltd. Registration number: 2018330000434 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191209 Granted publication date: 20130227 Pledgee: China Everbright Bank Limited by Share Ltd Hangzhou branch Pledgor: Zhejiang Kangnuobang Health Products Co., Ltd. Registration number: 2018330000434 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Skincare composition as well as use and method of same for preventing and delaying skin aging Effective date of registration: 20191211 Granted publication date: 20130227 Pledgee: China Everbright Bank Limited by Share Ltd Hangzhou branch Pledgor: Zhejiang Kangnuobang Health Products Co., Ltd. Registration number: Y2019330000289 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201123 Granted publication date: 20130227 Pledgee: China Everbright Bank Limited by Share Ltd. Hangzhou branch Pledgor: ZHEJIANG CANOBANK HEALTH PRODUCTS Co.,Ltd. Registration number: Y2019330000289 |